First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT - Get Free Report)'s stock price reached a new 52-week high on Monday . The stock traded as high as GBX 1,633.60 ($21.21) and last traded at GBX 1,600.90 ($20.79), with a volume of 0 shares changing hands. The stock had previously closed at GBX 1,609.10 ($20.89).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Trading Down 0.5 %
The firm has a market cap of £4.73 billion and a P/E ratio of -1,455.36. The firm's fifty day moving average is GBX 1,579.41 and its two-hundred day moving average is GBX 1,511.49. The company has a quick ratio of 9.27, a current ratio of 9.42 and a debt-to-equity ratio of 0.04.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
(
Get Free Report)
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
See Also
Before you consider First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation wasn't on the list.
While First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.